All Infectious Disease articles – Page 75
-
NewsScientists advance nanobody technology to combat deadly Ebola virus
Researchers have developed the first nanobody-based inhibitors targeting the Ebola virus. Their small size allows them to access areas of the virus and human tissues that larger antibodies cannot.
-
NewsDecoding the WHO Global Tuberculosis Report 2024: A critical analysis of global and Chinese key data
A new paper provides an in-depth interpretation of the WHO Global Tuberculosis Report 2024, analyzes global TB trends, updates the status of drug-resistant TB, discusses the intersection between TB and HIV, and summarizes the implications of the pandemic on TB control efforts.
-
NewsExeter launches second round of global funding to tackle antifungal drug resistance
A University of Exeter funding scheme designed to combat the global challenge of fungal antimicrobial resistance (fAMR) has announced a new call for applications.
-
NewsStudy shows head trauma may activate latent viruses, leading to neurodegeneration
Researchers have uncovered mechanisms that may connect the dots between trauma and the emergence of disease, pointing to latent viruses lurking in most of our brains that may be activated by the jolt, leading to inflammation and accumulating damage.
-
NewsTuberculosis strains resistant to new drugs are transmitted between patients
Researchers have identified 514 Mycobacterium tuberculosis strains that are resistant to TB drugs, including both old and new treatment regimens, in 27 countries across four continents. 28% of these strains were transmitted directly from one patient to another.
-
NewsOvercoming resistance: McMaster researchers find new utility for old antibiotics
In a recent study, researchers found that zinc plays a vital role in how some of the world’s most dangerous bacteria resist antibiotics.
-
NewsAs prevention strategy for sexually transmitted infections rolls out, experts highlight both promise and knowledge gaps
Real-world evidence demonstrates that the postexposure strategy of doxy PEP is reducing the rate of syphilis and chlamydia, but has had little to no effect on gonorrhea and needs close monitoring for signals of antibiotic resistance.
-
NewsNew study shows plummeting STIs with doxyPEP use
A new study has found that rates of chlamydia and syphilis plummet among people prescribed doxycycline for sexually transmitted infection prevention in routine clinical care.
-
NewsStudy traces Ebola’s route to the skin surface
Researchers have traced a cellular route the Ebola virus uses to traverse the inner and outer layers of skin and emerge onto the skin’s surface. The study identifies new cell types within the skin that are targeted by EBOV during infection.
-
NewsSystem to auto-detect new variants will inform better response to future infectious disease outbreaks
Researchers have come up with a new way to identify more infectious variants of viruses or bacteria that start spreading in humans - including those causing flu, COVID, whooping cough and tuberculosis.
-
NewsDiarrheal diseases remain a leading killer for children under 5, adults 70+
A new global study reports a 60% drop in global mortality from diarrheal diseases, but children and the elderly still have the highest death rates, particularly in sub-Saharan Africa and South Asia.
-
NewsSyphilis had its roots in the Americas, archaeological bone reveals
New research supports a root in the Americas for syphilis and its known relatives, and their introduction to Europe starting in the late 15th century is most consistent with the data, scientists say.
-
NewsCases of whooping cough growing, but knowledge about it is lacking
Many in the public are not familiar with symptoms of whooping cough. Almost a third of respondents (30%) are not sure if pertussis is the same as whooping cough and not sure (30%) whether a vaccine exists to prevent it.
-
NewsStudy shows drop in use of antiviral medications in young children with influenza
Despite national medical guidelines supporting the use of antiviral medications in young children diagnosed with influenza, a recent study reports an underuse of the treatment.
-
NewsGenome researchers unfurl protective mantle of influenza virus
The structure of the flu virus’s protective mantle and its interactions with its RNA have been described on an atomic scale by a research team for the first time.
-
NewsBreakthrough infection test designed to tackle AMR on target for 2025 UK NHS availability after positive trial results
UK medtech company Presymptom Health has announced positive results from its clinical trial of diagnostic technology in the management of infection and sepsis in patients presenting to Emergency Departments with respiratory infection.
-
NewsStudy assesses virulence of Cryptococcus strains, laying groundwork for improved treatment
A research group has just completed a six-year study to examine the virulence of 38 clinical isolates from various strains of Cryptococcus, taking us a step closer towards improved treatment of the fungal pathogen.
-
NewsDisney princesses face hidden health risks, including zoonotic infections, warn experts
Although Disney princesses seem to live happily ever after, they face serious real world health hazards, warn experts in the Christmas edition of the BMJ.
-
NewsStaphylococcus aureus thwarts vaccines by turning on a protein that halts immune response
Approximately 30 clinical trials to date have failed to result in an effective human vaccine for Staphylococcus aureus but researchers have now identified a key reason for these failures, indicating that it may be possible to modify the vaccines to work in humans.
-
NewsDeadly mould strains highly likely to acquire resistance to new drugs
Scientists have identified strains of one of the world’s most dangerous fungal pathogens, already resistant to our most effective antifungal drugs, which are also five times more likely to acquire resistance to desperately needed new treatments in development. Source: Ufficio Comunicazione, Azienda Ospedaliera SS. Antonio e ...